SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014616
Filing Date
2023-05-15
Accepted
2023-05-15 16:32:18
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20230331_10q.htm   iXBRL 10-Q 579083
2 EXHIBIT 31.1 ex_513814.htm EX-31.1 13289
3 EXHIBIT 31.2 ex_513815.htm EX-31.2 13281
4 EXHIBIT 32.1 ex_513816.htm EX-32.1 5033
5 EXHIBIT 32.2 ex_513817.htm EX-32.2 5156
11 pipeline.jpg GRAPHIC 65326
  Complete submission text file 0001437749-23-014616.txt   3921114

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230331.xsd EX-101.SCH 42932
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230331_def.xml EX-101.DEF 293902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230331_lab.xml EX-101.LAB 229015
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230331_pre.xml EX-101.PRE 316711
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20230331_cal.xml EX-101.CAL 32163
59 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230331_10q_htm.xml XML 449674
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 23923236
SIC: 2834 Pharmaceutical Preparations